ArticleJournal of personalized medicine2022

Systematic Analysis of Cellular Signaling Pathways and Therapeutic Targets for SLC45A3:ERG Fusion-Positive Prostate Cancer.

Jongsu Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.